Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to explore the possible cognitive effects of oxybutynin tablets and oxybutynin gel.

Key facts

Study ID

NCT00752141

Run by

Watson Pharmaceuticals

People needed

153

Starts

2008-09-01

Last updated by the study team

2011-09-23

Who can join

Age: 60 and older, up to 79. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males and females aged 60 and over
• English as a primary language
• Given written informed consent by signing and dating an informed consent form prior to study entry

You may not qualify if…

• Current diseases in which the use of oxybutynin is contraindicated
• History of narrow-angle glaucoma or urinary or gastric retention
• Current use of drugs known to effect memory and cognition
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Study site — Tucson, Arizona, United States
• Study site — National City, California, United States
• Study site — Maitland, Florida, United States
• Study site — Naples, Florida, United States
• Study site — Ocala, Florida, United States
• Study site — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.